Biomarin Pharmaceutical Inc (BMRN)

Current ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total current assets	US$ in thousands	2,956,090	2,751,460	2,274,380	2,342,220	1,942,140
Total current liabilities	US$ in thousands	1,177,020	588,884	546,497	492,548	932,503
Current ratio		2.51	4.67	4.16	4.76	2.08

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $2,956,090K ÷ $1,177,020K
= 2.51

The current ratio of Biomarin Pharmaceutical Inc has fluctuated over the past five years, ranging from 2.08 in 2019 to 4.67 in 2022. As of December 31, 2023, the current ratio stands at 2.51, indicating a decrease from the previous year. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A current ratio above 1 suggests that the company can meet its short-term obligations. Biomarin's current ratio has generally been above 2 in recent years, demonstrating a healthy liquidity position. However, the decrease in the current ratio from the prior year may signal a potential reduction in the company's short-term liquidity. Further analysis is recommended to understand the factors contributing to this change and assess its impact on the company's financial health.